1. The effect of the local anaesthetic, butacaine, on adenine nucleotide binding and translocation in rat liver mitochondria partially depleted of their adenine nucleotide content was investigated. 2. The range of butacaine concentrations that inhibit adenine nucleotide translocation and the extent of the inhibition are similar to the values obtained for native mitochondria. 3. Butacaine does not alter either the total number of atractyloside-sensitive binding sites of depleted mitochondria, or the affinity of these sites for ADP or ATP under conditions where a partial inhibition of the rate of adenine nucleotide translocation is observed. 4. The data are consistent with an effect of butacaine on the process by which adenine nucleotides are transported across the mitochondrial inner membrane rather than on the binding of adenine nucleotides to sites on the adenine nucleotide carrier. 5. The results are briefly discussed in relation to the use of local anaesthetics in investigations of the mechanism of adenine nucleotide translocation.
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Studies in this laboratory have shown that local anaesthetics, of which butacaine is the most potent, alter the rate of adenine nucleotide translocation across the inner membrane of rat liver mitochondria. A stimulation of translocation is observed at low concentrations of both adenine nucleotide and anaesthetic, whereas the presence of higher concentrations of these leads to an inhibition of translocation (Spencer & Bygrave, 1974) .
This report describes the results of experiments designed to define further the effect of butacaine on adenine nucleotide translocation. It is shown that in rat liver mitochondria partially depleted of their adenine nucleotide content, butacaine does not alter the binding of ADP or ATP to atractyloside-sensitive sites under conditions where the rate of adenine nucleotide translocation is inhibited. These results are discussed in relation to the mechanism(s) by which butacaine inhibits adenine nucleotide translocation, and the use of local anaesthetics as a specific means of studying the mechanism of translocation.
Experimental Mitochondria
Mitochondria were isolated from the livers of 200g male rats (Wistar albino), and their protein concentration and respiratory properties determined as described by Reed & Bygrave (1974) .
Vol. 148
Depletion of endogenous adenine nucleotides Partial depletion of the adenine nucleotide content of mitochondria was achieved by incubation in a medium containing 50mM-sucrose, 5OmM-K2HPO4 adjusted to pH7.4 with KOH, 5mM-MgCI2 and 0.25mg of mitochondrial protein/ml as described by Erdelt et al. (1972) . After depletion, the mitochondria were washed once in 250mM-sucrose containing 10mM-Hepes* (pH7.4) and 2mM-EGTA and finally suspended in 250mM-sucrose containing 5mM-Hepes (pH 7.0).
Binding of adenine nucleotides to atractylosidesensitive binding sites
The binding of ADP or ATP to atractylosidesensitive sites on depleted mitochondria was measured at 0°C in a medium that contained (in a final volume of 0.4ml) 250mM-sucrose, 5mM-Hepes, 5mM-Mes (pH 7.0), 2mm-EGTA, 1 mM-adenine 3'-monophosphate, 2mg of depleted mitochondria/ml and ADP or ATP and butacaine at the concentrations indicated. For the measurement of ATP binding, oligomycin (124ug/ml) was included in the medium (Weidemann et al., 1970) . The specific radioactivity of exogenous adenine nucleotides was corrected for dilution by unlabelled endogenous adenine nucleotides (Morris, 1971 were determined from the measured radioactivity in the three parallel binding samples (cf. Weidemann et al.,-1970) by standard procedures of statistical analysis.
Rate of adenine nucleotide translocation
The rate of adenine nucleotide translocation was measured at 0°C in a medium identical with that used for the measurement of adenine nucleotide binding by forward exchange as described by Spencer & Bygrave (1972) . The standard deviation of values obtained for the rate of adenine nucleotide translocation was estimated by measuring the rate of translocation under a fixed set of conditions in a number of independent assays; S.D. was ±6% of the mean value.
Analytical methods ATP, and ADP and AMP were assayed as described by Lamprecht & Trautschold (1965) and Adam (1965) respectively. Adenine nucleotides were separated chromatographicallyas described by Morrison (1968) .
Chemicals
["C]ADP and [1"C]ATP were obtained from The Radiochemical Centre, Amersham, Bucks., U.K. Butacaine sulphate was a gift from Abbot Australasia Pty. Ltd., Carlton, N.S.W., Australia. All other reagents were of analytical grade.
Results

Inhibitionz of adenine nucleotide translocationi in depleted mitochondria
Accurate measurement of the binding of adenine nucleotides to atractyloside-sensitive binding sites on mitochondria by the method of Weidemann et al. (1970) can be made only if the concentration of endogenous adenine nucleotides is low. Rat liver mitochondria that had been partially depleted of their endogenous adenine nucleotides by treatment with potassium phosphate buffer (see the Experimental section) were found to have low acceptor control ratios, and much smaller pools of total and exchangeable adenine nucleotides when compared with native mitochondria (Table 1 ). The rate of ADP translocation in depleted mitochondria is about 50% of that observed in native mitochondria. Since the properties of depleted mitochondria differ from those of native mitochondria (Table 1 and Weidemann et al., 1970) it was important to establish that the effect of butacaine on adenine nucleotide translocation in depleted mitochondria is similar to that observed in native mitochondria. The rate of ADP translocation was measured in both native and depleted mitochondria in the presence of increasing concentrations of butacaine (50-450pM). No difference was observed in either the maximum inhibition (68 %) or the concentration of butacaine (76,AM) that gives half-maximum inhibition (cf. Spencer & Bygrave, 1974) . This result indicates that butacaine has similar effects on adenine nucleotide translocation in depleted and native mitochondria.
Effect of butacaine on adenine nucleotide binding at high concentrations of adenine nucleotide Maximum inhibition by butacaine of adenine nucleotide translocation in native rat liver mitochondria is observed at high concentrations (100-400AM) of adenine nucleotides (Spencer & Bygrave, 1974) . The effect of butacaine on the binding of ADP to atractyloside-sensitive sites on depleted mitochondria was therefore tested at the highest concentration of adenine nucleotide (100pUM) at which accurate estimations of the amount of binding can be made. Fig. 1(a) shows the effect of butacaine on the amount of ADP bound to non-specific sites, the sum of the amounts ofADP bound to non-specific sites and translocated at 2min and the sum of the amounts ofADP bound to tion-specific and atractyloside-sensitive sites and translocated at 2min. Buta- (Fig. ic) as well as the amount of ADP translocated at 2min (Fig. la) . In particular, at 100,PM-ADP, where ADP translocation is inhibited by almost 50% (cf. Spencer & Bygrave, 1974) , butacaine has no effect on the binding ofADP to atractyloside-sensitive sites (Fig. lb) . Butacaine also has no effect on the binding of ATP to atractyloside-sensitive sites (Fig. 2a) at 100puM-ATPunder conditions where a significant inhibition of the rate of ATP translocation is observed (Fig. 2b) . These data, which were obtained at sufficient concentrations of either ADP or ATP to saturate binding, indicate that butacaine does not alter the total number of atractyloside-sensitive binding sites on the mitochondrial inner membrane.
Effect of butacaine on the affinity of the adenine nucleotide translocase for ADP or ATP
The effect of butacaine on the binding of adenine nucleotides to atractyloside-sensitive sites was investigated at low concentrations of adenine nucleotide to determine whether butacaine alters the affinity of the translocase for adenine nucleotides. Butacaine did not effect the amount of ADP or ATP bound to atractyloside-sensitive sites at 3pM-ADP or -ATP when the concentration of butacaine was varied from 30 to 500pM (results not shown).
The amount of ADP bound to atractylosidesensitive binding sites was measured over a range of ADP concentrations in the presence and absence of a fixed concentration (100pUM) of butacaine. No significant difference between the data obtained in the presence or the absence of butacaine was observed (Fig. 3a) . Similar results were obtained for ATP (Fig. 3b) , although the range of ATP concentrations tested was less extensive. Thus it is concluded that butacaine does not alter the affinity of the adenine nucleotide translocase for ADP or ATP.
Discussion
The influence of butacaine on the rate of adenine nucleotide translocation could involve an effect on (a) the binding of adenine nucleotides to the atractyloside-sensitive binding sites on the translocase protein, (b) the translocation of adenine nucleotides across the mitochondrial inner membrane, (c) their release from the carrier protein or (d) an effect on a combination of these processes. The present results show that in depleted mitochondria, butacaine does not alter either the total number of atractyloside-sensitive binding sites, or the affinity of these sites for adenine nucleotides under conditions where the rate of adenine nucleotide translocation is inhibited. Moreover, the binding of The experimental procedures and incubation conditions were as described in Fig. 1 , with the replacement ofADP by 100pM-ATP and the inclusion of oligomycin (12,ug/ml) in the incubation medium. adenine nucleotides to atractyloside-sensitive sites measured under the conditions described here represents binding to carrier sites that face both sides of the inner mitochondrial membrane (Klingenberg et al., 1973) . Therefore it is concluded that butacaine affects the process by which adenine nucleotides are translocated through the mitochondrial inner membrane, rather than adenine nucleotide binding to, or release from, sites on the adenine nucleotide translocase. Comparison of the inhibition of adenine nucleotide translocation by butacaine in native and depleted mitochondria indicates that the effect (and hence mechanism of action) of butacaine on this process in native mitochondria is similar to its effect on depleted mitochondria.
The effect of butacaine on mitochondria appears to be relatively specific for adenine nucleotide trans- Together with the lack of effect of butacaine on adenine nucleotide binding, these observations are consistent with the idea that butacaine inhibits adenine nucleotide translocation by its interaction with phospholipids, which form the phospholipid environment of the translocase, leading to an alteration in the rate of the translocation process (Spencer & Bygrave, 1972 . The mechanism(s) by which butacaine interacts with these phospholipids is at present unknown, although it is likely to involve both electrostatic and hydrophobic interactions (Ritchie & Greengard, 1966; Seeman, 1972; Cerbon, 1972; Butler et al., 1973) . Perhaps more, importantly the present observations suggest that butacaine and related compounds can be used as specific inhibitors in physicochemical investigations of the mechanism of the process by which adenine nucleotides are translocated through the inner mitochondrial membrane.
